- 商品介绍
- 规格参数
- 包装参数
产品介绍
Product Description
QIAseq DIRECT SARS-CoV-2 Kits are specially designed to advance research into SARS-CoV-2, which is the causative agent of COVID-19 disease. These kits are single-box solutions for sequencing the entire viral genome. SARS-CoV-2 is encoded by a positive-sense, single-stranded RNA molecule that can be mixed with host RNA during isolation from a sample. The kits include reagents to reverse transcribe the RNA into cDNA, primers to specifically enrich for the viral genome and Unique Dual Indices (UDIs) for sequencing. The panel consists of approximately 550 primers for creating 425 amplicons, covering the entire SARS-CoV-2 viral genome.
.
产品特点
Features
- Works with all known Variants of Concern, including Omicron
- Fast, 4-hour workflow with no need for fragmentation or ligation reactions
- Highly uniform whole genome coverage for SARS-CoV-2
- A 50% reduction in tip usage compared to ARTIC-based workflows
- High library yields even from low copy number samples
产品应用
Applications
The QIAseq DIRECT SARS-CoV-2 Kit can be used to achieve whole genome coverage of the SARS-CoV-2 viral genome for epidemiological research and genomic surveillance purposes.
With the ability to multiplex up to 384 samples, the panel allows labs to rapidly scale up sequencing capabilities and ramp up SARS-CoV-2 genomic surveillance efforts. Accurate amplification and high SARS-CoV-2 genome coverage enables the detection of new variants with unparalleled precision.
长度(mm) | |
宽度(mm) | |
高度(mm) | |
重量(kg) |
猜你喜欢